These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antioxidant and C5a-blocking strategy for hepatic ischemia-reperfusion injury repair. Zhang X, Hu J, Becker KV, Engle JW, Ni D, Cai W, Wu D, Qu S. J Nanobiotechnology; 2021 Apr 15; 19(1):107. PubMed ID: 33858424 [Abstract] [Full Text] [Related]
5. CAAT/enhancer binding protein-homologous protein deficiency attenuates liver ischemia/reperfusion injury in mice. Wada S, Hatano E, Yoh T, Nakamura N, Okuda Y, Okuno M, Kasai Y, Iwaisako K, Seo S, Taura K, Uemoto S. Liver Transpl; 2018 May 15; 24(5):645-654. PubMed ID: 29524333 [Abstract] [Full Text] [Related]
9. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease. Thrane AS, Skehan JD, Thrane PS. Med Hypotheses; 2007 May 15; 68(6):1363-70. PubMed ID: 17169498 [Abstract] [Full Text] [Related]
10. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA. Transplantation; 2003 Feb 15; 75(3):375-82. PubMed ID: 12589162 [Abstract] [Full Text] [Related]
11. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. Arumugam TV, Woodruff TM, Stocks SZ, Proctor LM, Pollitt S, Shiels IA, Reid RC, Fairlie DP, Taylor SM. J Hepatol; 2004 Jun 15; 40(6):934-41. PubMed ID: 15158333 [Abstract] [Full Text] [Related]
12. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW, Xu N, Xia Q, Kupiec-Weglinski JW, Ji H. J Hepatol; 2019 Oct 15; 71(4):719-730. PubMed ID: 31201834 [Abstract] [Full Text] [Related]
14. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage. Fung M, Lu M, Fure H, Sun W, Sun C, Shi NY, Dou Y, Su J, Swanson X, Mollnes TE. Clin Exp Immunol; 2003 Aug 15; 133(2):160-9. PubMed ID: 12869020 [Abstract] [Full Text] [Related]
16. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy. Williams AL, Gullipalli D, Ueda Y, Sato S, Zhou L, Miwa T, Tung KS, Song WC. Kidney Int; 2017 Jun 15; 91(6):1386-1397. PubMed ID: 28139294 [Abstract] [Full Text] [Related]
18. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. Sewell DL, Nacewicz B, Liu F, Macvilay S, Erdei A, Lambris JD, Sandor M, Fabry Z. J Neuroimmunol; 2004 Oct 01; 155(1-2):55-63. PubMed ID: 15342196 [Abstract] [Full Text] [Related]